Muscle preservation usually requires adequate protein, resistance training, enough total nutrition, hydration, and medical monitoring when needed
In a 26-week study, orforglipron demonstrated a significant dose-dependent effect on weight loss, with weight reduction ranging from 8.6% to 12.6% across various dosages, compared to only 2.0% in the placebo group
Weaning off tirzepatide requires the same patience and monitoring as the initial dose escalation phase
Laboratory models have recorded improvements in exercise tolerance, muscle performance, and metabolic balance following MOTS-c exposure under controlled conditions, making it a practical tool for geroscience and longevity research
For patients with persistent reflux symptoms despite 8 weeks of PPI therapy or those with alarm features, referral to gastroenterology for upper endoscopy may be warranted, consistent with American College of Gastroenterology guidelines